Olfactory receptor surface expression is driven by association with the β2-adrenergic receptor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 37, 2004, Pages 13672-13676

  Hague, Chris ^a   Uberti, Michelle A ^a   Chen, Zhongjian ^a   Bush, Cristina F ^a   Jones, Seth V ^a   Ressler, Kerry J ^a   Hall, Randy A ^a   Minneman, Kenneth P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOPHENONE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; LIGAND; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; EMBRYO CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; INTERNALIZATION; KIDNEY CELL; NERVE CELL; NONHUMAN; OLFACTORY EPITHELIUM; OLFACTORY RECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SURFACE PROPERTY; WILD TYPE;

ANIMALS; CELL LINE; CELL MEMBRANE; ENDOCYTOSIS; EPITHELIUM; GENE EXPRESSION REGULATION; HUMANS; MICE; MICROSCOPY, CONFOCAL; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ODORANT; RNA, MESSENGER;

ANIMALIA;

EID: 4544226342     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0403854101     Document Type: Article

References (43)

1. Barber, R. D. & Ronnett, G. V. (2000) Mol. Neurobiol. 21, 161-173.
2. Buck, L. B. (2000) Cell 100, 611-618.
3. Mombaerts, P. (2004) Nat. Rev. Neurosci. 5, 263-278.
4. Malnic, B., Godfrey, P. A. & Buck, L. B. (2004) Proc. Natl. Acad. Sci. USA 101, 2584-2589.
5. Godfrey, P. A., Malnic, B. & Buck, L. B. (2004) Proc. Natl. Acad. Sci. USA 101, 2156-2161.
6. Chess, A., Simon, I., Cedar, H. & Axel, R. (1994) Cell 78, 823-834.
7. McClintock, T. S. & Sammeta, N. (2003) NeuroReport 14, 1547-1552.
8. Li, J., Ishii, T., Feinstein, P. & Mombaerts, P. (2004) Nature 428, 393-399.
9. Kawai, F., Kurahashi, T. & Kaneko, A. (1999) Nat. Neurosci. 2, 133-138.
10. Krautwurst, D., Yau, K. W. & Reed, R. R. (1998) Cell 95, 917-926.
11. Kajiya, K., Inaki, K., Tanaka, M., Haga, T., Kataoka, H. & Touhara, K. (2001) J. Neurosci. 21, 6018-6025.
12. Bozza, T., Feinstein, P., Zheng, C. & Mombaerts, P. (2002) J. Neurosci. 22, 3033-3043.
13. Oka, Y., Omura, M., Kataoka, H. & Touhara, K. (2004) EMBO J. 23,120-126.
14. Gantz, I., Schaffer, M., DelValle, J., Logsdon, C., Campbell, V., Uhler, M. & Yamada, T. (1991) Proc. Natl. Acad. Sci. USA 88, 429-433.
15. Gimelbrant, A. A., Stoss, T. D., Landers, T. M. & McClintock, T. S. (1999) J. Neurochem. 72, 2301-2311.
16. Wetzel, C. H., Oles, M., Wellerdieck, C., Kuczkowiak, M., Gisselmann, G. & Hatt, H. (1999) J. Neurosci. 19, 7426-7433.
17. Ivic, L., Zhang, C., Zhang, X., Yoon, S. O. & Firestein, S. (2002) J. Neurobiol. 50, 56-68.
18. Levasseur, G., Persuy, M. A., Grebert, D., Remy, J. J., Salesse, R. & Pajot-Augy, E. (2003) Eur. J. Biochem. 270, 2905-2912.
19. McCune, D. F., Edelmann, S. E., Olges, J. R., Post, G. R., Waldrop, B. A., Waugh, D. J., Perez, D. M. & Piascik, M. T. (2000) Mol. Pharmacol. 57, 659-666.
20. Chalothorn, D., McCune, D. F., Edelmann, S. E., Garcia-Cazarin, M. L., Tsujimoto, G. & Piascik, M. T. (2002) Mol. Pharmacol. 61, 1008-1016.
21. Hague, C., Chen, Z., Pupo, A. S., Schulte, N. A., Toews, M. L. & Minneman, K. P. (2004) J. Pharmacol. Exp. Ther. 309, 388-397.
22. von Zastrow, M., Link, R., Daunt, D., Barsh, G. & Kobilka, B. (1993) J. Biol. Chem. 268, 763-766.
23. Sitaraman, S. V., Wang, L., Wong, M., Bruewer, M., Hobert, M., Yun, C. H., Merlin, D. & Madara, J. L. (2002) J. Biol. Chem. 277, 33188-33195.
24. Chandrashekar, J., Mueller, K. L., Hoon, M. A., Adler, E., Feng, L., Guo, W., Zuker, C. S. & Ryba, N. J. (2000) Cell 100, 703-711.
25. Uberti, M. A., Hall, R. A. & Minneman, K. P. (2003) Mol. Pharmacol. 64, 1379-1390.
26. Hague, C., Uberti, M. A., Chen, Z., Hall, R. A. & Minneman, K. P. (2004) J. Biol. Chem. 279, 15541-15549.
27. Buck, L. & Axel, R. (1991) Cell 65, 175-187.
28. Vicentic, A., Robeva, A., Rogge, G., Uberti, M. & Minneman, K. P. (2002) J. Pharmacol. Exp. Ther. 302, 58-65.
29. Pupo, A. S., Uberti, M. A. & Minneman, K. P. (2003) Eur. J. Pharmacol. 462, 1-8.
30. Guerrero, S. W. & Minneman, K. P. (1999) J. Pharmacol. Exp. Ther. 290, 980-988.
31. Ressler, K. J., Sullivan, S. L. & Buck, L. B. (1993) Cell 73, 597-609.
32. Ressler, K. J., Sullivan, S. L. & Buck, L. B. (1994) Cell 79, 1245-1255.
33. Kohout, T. A. & Lefkowitz, R. J. (2003) Mol. Pharmacol. 63, 9-18.
34. Marshall, F. H., Jones, K. A., Kaupmann, K. & Bettler, B. (1999) Trends Pharmacol. Sci. 20, 396-399.
35. Nelson, G., Hoon, M. A., Chandrashekar, J., Zhang, Y., Ryba, N. J. & Zuker, C. S. (2001) Cell 106, 381-390.
36. Nelson, G., Chandrashekar, J., Hoon, M. A., Feng, L., Zhao, G., Ryba, N. J. & Zuker, C. S. (2002) Nature 416, 199-202.
37. Pin, J. P. & Acher, F. (2002) Curr. Drug Target CNS Neurol. Disord. 1, 297-317.
38. Bouvier, M. (2001) Nat. Rev. Neurosci. 2, 274-286.
39. Salahpour, A., Angers, S., Mercier, J. F., Lagace, M., Marullo, S. & Bouvier, M. (2004) J. Biol. Chem. 279, 33390-33397.
40. Dawson, T. M., Arriza, J. L., Jaworsky, D. E., Borisy, F. F., Attramadal, H., Lefkowitz, R. J. & Ronnett, G. V. (1993) Science 259, 825-829.
41. Peppel, K., Boekhoff, I., McDonald, P., Breer, H., Caron, M. G. & Lefkowitz, R. J. (1997) J. Biol. Chem. 272, 25425-25428.
42. Firestein, S. & Shepherd, G. M. (1992) NeuroReport 3, 661-664.
43. Shepherd, G. M. & Firestein, S. (1991) J. Steroid Biochem. Mol. Biol. 39, 583-592.